Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice

Arthritis and Rheumatism

Volumn 60, Issue 6, 2009, Pages 1775-1784

  Hughes, Grant C ^a,b   Martin, David ^a   Zhang, Kang ^a   Hudkins, Kelly L ^a   Alpers, Charles E ^a   Clark, Edward A ^a   Elkon, Keith B ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; COMPLEMENT; COMPLEMENT COMPONENT C3; DNA ANTIBODY; DOUBLE STRANDED DNA; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; MEDROXYPROGESTERONE ACETATE; PROGRAMMED DEATH LIGAND 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG MEGADOSE; FEMALE; GLOMERULONEPHRITIS; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOCYTE; MORTALITY; MOUSE; NEW ZEALAND BLACK MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; SPLEEN CELL; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TREATMENT RESPONSE;

ANIMALS; ANTIGENS, CD86; AUTOANTIBODIES; COMPLEMENT C3; DISEASE MODELS, ANIMAL; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLOMERULONEPHRITIS; IMMUNOGLOBULIN G; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEDROXYPROGESTERONE 17-ACETATE; MICE; MICE, INBRED NZB; PROGESTERONE; PROTEINURIA; TH1 CELLS;

EID: 66449123868     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24548     Document Type: Article

References (49)

1. Hughes GC, Clark EA. Regulation of dendritic cells by female sex steroids: relevance to immunity and autoimmunity. Autoimmunity 2007;40:470-481 (Pubitemid 47343359)
2. Ackerman LS. Sex hormones and the genesis of autoimmunity. Arch Dermatol 2006;142:371-376
3. Petri M. Sex hormones and systemic lupus erythematosus. Lupus 2008;17:412-415
4. Ronnblom L, Eloranta ML, Alm GV. The type 1 interferon system in systemic lupus erythematosus [review]. Arthritis Rheum 2006;54:408-420 (Pubitemid 43228615)
5. Theofilopoulos AN, Baccala R, Beutler B, Kono DH. Type 1 interferons (α/β) in immunity and autoimmunity. Annu Rev Immunol 2005;23:307-336 (Pubitemid 40563172)
6. Hughes GC, Thomas S, Li C, Kaja MK, Clark EA. Cutting edge: progesterone regulates IFN-α production by plasmacytoid dendritic cells. J Immunol 2008;180:2029-2033
7. Li J, McMurray RW. Effects of estrogen receptor subtype-selective agonists on autoimmune disease in lupus-prone NZB/W F1 mouse model. Clin Immunol 2007;123:219-226 (Pubitemid 46591958)
8. Peeva E, Zouali M. Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes. Immunol Lett 2005;101:123-143 (Pubitemid 41368071)
9. Keisler LW, Kier AB, Walker SE. Effects of prolonged administration of the 19-nor-testosterone derivatives norethindrone and norgestrel to female NZB/W mice: comparison with medroxyprogesterone and ethinyl estradiol. Autoimmunity 1991;9:21-32.
10. Roubinian J, Talal N, Siiteri PK, Sadakian JA. Sex hormone modulation of autoimmunity in NZB/NZW mice. Arthritis Rheum 1979;22:1162-1169 (Pubitemid 10163780)
11. Miyaura H, Iwata M. Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol 2002;168:1087-1094 (Pubitemid 34094472)
12. Lahita RG. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 1999;11:352-356
13. Arnalich F, Benito-Urbina S, Gonzalez-Gancedo P, Iglesias E, de Miguel E, Gijon-Banos J. Inadequate production of progesterone in women with systemic lupus erythematosus. Br J Rheumatol 1992;31:247-251
14. Medeiros PB, Febronio MV, Bonfa E, Borba EF, Takiuti AD, Silva CA. Menstrual and hormonal alterations in juvenile systemic lupus erythematosus. Lupus 2009;18:38-43.
15. Chan RW, Lai FM, Li EK, Tam LS, Chow KM, Li PK, et al. Imbalance of Th1/Th2 transcription factors in patients with lupus nephritis. Rheumatology (Oxford) 2006;45:951-957 (Pubitemid 44283048)
16. Theofilopoulos AN, Koundoris S, Kono DH, Lawson BR. The role of IFN-γ in systemic lupus erythematosus: a challenge to the Th-1/Th-2 paradigm in autoimmunity. Arthritis Res 2001;3:136-144 (Pubitemid 32303429)
17. Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L, et al. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum 2000;43:76-84. (Pubitemid 30368215)
18. Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK. Activation of the interferon-α pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 2005;52:1491-1503 (Pubitemid 40663941)
19. Depo-Provera, product monograph. Canada: Pfizer; 2006.
20. Taneda S, Segerer S, Hudkins KL, Cui Y, Wen M, Segerer M, et al. Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice. Am J Pathol 2001;159:2355-2369 (Pubitemid 33104288)
21. Georgiev M, Agle LM, Chu JL, Elkon KB, Ashany D. Mature dendritic cells readily break tolerance in normal mice but do not lead to disease expression. Arthritis Rheum 2005;52:225-238 (Pubitemid 40129252)
22. Watanabe C, Shu GL, Zheng TS, Flavell RA, Clark EA. Caspase 6 regulates B cell activation and differentiation into plasma cells. J Immunol 2008;181:6810-6819
23. Kaushic C, Ashkar AA, Reid LA, Rosenthal KL. Progesterone increases susceptibility and decreases immune responses to genital herpes infection. J Virol 2003;77:4558-4565 (Pubitemid 36402805)
24. Palmieri D, Halverson DO, Ouatas T, Horak CE, Salerno M, Johnson J, et al. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. J Natl Cancer Inst 2005;97:632-642 (Pubitemid 40812627)
25. Nishimura R, Nagao K, Matsuda M, Baba K, Matsuoka Y, Yamashita H, et al. Predictive value of serum medroxyprogesterone acetate concentration for response in advanced or recurrent breast cancer. Eur J Cancer 1997;33:1407-1412 (Pubitemid 27404898)
26. Etienne MC, Milano G, Frenay M, Renee N, Francois E, Thyss A, et al. Pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate in advanced breast cancer patients [published erratum appears in J Clin Oncol 1992;10:1988]. J Clin Oncol 1992;10:1176-1182
27. Helyer BJ, Howie JB. Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice. Nature 1963;197:197.
28. Lambert PH, Dixon FJ. Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med 1968;127:507-522
29. Channing AA, Kasuga T, Horowitz RE, Dubois EL, Demopoulos HB. An ultrastructural study of spontaneous lupus nephritis in the NZB-BL-NZW mouse. Am J Pathol 1965;47:677-694
30. Schiffer L, Bethunaickan R, Ramanujam M, Huang W, Schiffer M, Tao H, et al. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol 2008;180:1938-1947
31. Nimmerjahn F, Ravetch J. Fc-′ receptors: old friends and new family members. Immunity 2006;24:19-28. (Pubitemid 43077197)
32. Clynes R, Dumitru C, Ravetch JV. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 1998;279:1052-1054 (Pubitemid 28113310)
33. Kalaaji M, Mortensen E, Jorgensen L, Olsen R, Rekvig OP. Nephritogenic lupus autoantibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells. Am J Pathol 2006;168:1779-1792 (Pubitemid 43825300)
34. Baudino L, Azeredo da Silveira S, Nakata M, Izui S. Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies. Springer Semin Immunopathol 2006;28:175-184
35. Steward MW, Hay FC. Changes in immunoglobulin class and subclass of anti-DNA antibodies with increasing age in N/ZBW F1 hybrid mice. Clin Exp Immunol 1976;26:363-370
36. Roubinian JR, Talal N, Greenspan JS, Goodman JR, Siiteri PK. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med 1978;147:1568-1583 (Pubitemid 8372952)
37. Moro MH, Bjornsson J, Marietta EV, Hofmeister EK, Germer JJ, Bruinsma E, et al. Gestational attenuation of Lyme arthritis is mediated by progesterone and IL-4. J Immunol 2001;166:7404-7409 (Pubitemid 32525617)
38. 1 mouse. Arthritis Rheum 2005;52:3629-3638
39. Witte T. IgM antibodies against dsDNA in SLE. Clin Rev Allergy Immunol 2008;34:345-347
40. Vermeulen M, Pazos P, Lanari C, Molinolo A, Gamberale R, Geffner J, et al. Medroxyprogesterone acetate enhances in vivo and in vitro antibody production. Immunology 2001;104:80-86 (Pubitemid 32955398)
41. Quezada SA, Jarvinen LZ, Lind EF, Noelle RJ. CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol 2004;22:307-328 (Pubitemid 38680425)
42. Druckmann R, Druckmann MA. Progesterone and the immunology of pregnancy. J Steroid Biochem Mol Biol 2005;97:389-396
43. Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, et al. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 1990;9:1603-1614 (Pubitemid 20137018)
44. Elbourne KB, Keisler D, McMurray RW. Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 model of systemic lupus erythematosus. Lupus 1998;7:420-427 (Pubitemid 28410189)
45. Gomez F, Ruiz P, Briceno F, Lopez R, Michan A. Treatment with progesterone analogues decreases macrophage Fc-γ receptors expression. Clin Immunol Immunopathol 1998;89:231-239 (Pubitemid 28565109)
46. Slack JH, Hang L, Barkley J, Fulton RJ, D'Hoostelaere L, Robinson A, et al. Isotypes of spontaneous and mitogen-induced autoantibodies in SLE-prone mice. J Immunol 1984;132:1271-1275 (Pubitemid 14154549)
47. Miller L, Patton DL, Meier A, Thwin SS, Hooton TM, Eschenbach DA. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol 2000;96:431-439
48. Toubi E, Shoenfeld Y. The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 2004;37:457-464 (Pubitemid 40123415)
49. Lu Q, Shen N, Li XM, Chen SL. Genomic view of IFN-α response in pre-autoimmune NZB/W and MRL/lpr mice. Genes Immun 2007;8:590-603. (Pubitemid 350011691)